APA (7th ed.) Citation

Lai, S., Su, Y., Chi, C., Kuo, Y., Lee, K., Wu, Y., . . . Huang, Y. (2019). DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. Journal of experimental & clinical cancer research, 38(1), 474-18. https://doi.org/10.1186/s13046-019-1442-2

Chicago Style (17th ed.) Citation

Lai, Ssu-Chuan, et al. "DNMT3b/OCT4 Expression Confers Sorafenib Resistance and Poor Prognosis of Hepatocellular Carcinoma Through IL-6/STAT3 Regulation." Journal of Experimental & Clinical Cancer Research 38, no. 1 (2019): 474-18. https://doi.org/10.1186/s13046-019-1442-2.

MLA (9th ed.) Citation

Lai, Ssu-Chuan, et al. "DNMT3b/OCT4 Expression Confers Sorafenib Resistance and Poor Prognosis of Hepatocellular Carcinoma Through IL-6/STAT3 Regulation." Journal of Experimental & Clinical Cancer Research, vol. 38, no. 1, 2019, pp. 474-18, https://doi.org/10.1186/s13046-019-1442-2.